Overview

Bioequivalence of BIBR 277 Tablet Compared With Capsule in Healthy Male Volunteers

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Study to investigate the bioequivalence of BIBR 277 tablet (Erythritol based) vs. BIBR 277 capsule
Phase:
Phase 1
Details
Lead Sponsor:
Boehringer Ingelheim
Treatments:
Telmisartan